IMEQA Trademark

Trademark Overview


On Friday, February 11, 2011, a trademark application was filed for IMEQA with the United States Patent and Trademark Office. The USPTO has given the IMEQA trademark a serial number of 85240180. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, June 27, 2012. This trademark is owned by Glaxo Group Limited. The IMEQA trademark is filed in the Pharmaceutical Products category with the following description:

(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the trea...
imeqa

General Information


Serial Number85240180
Word MarkIMEQA
Filing DateFriday, February 11, 2011
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, June 27, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Services(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "IMEQA" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 16, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN

Trademark Events


Event DateEvent Description
Wednesday, June 27, 2012ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, June 27, 2012ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, November 21, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 21, 2011NON-FINAL ACTION E-MAILED
Monday, November 21, 2011NON-FINAL ACTION WRITTEN
Monday, November 21, 2011ASSIGNED TO EXAMINER
Monday, November 21, 2011ASSIGNED TO EXAMINER
Monday, November 14, 2011LIE CHECKED SUSP - TO ATTY FOR ACTION
Monday, November 14, 2011ASSIGNED TO LIE
Thursday, May 12, 2011NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, May 12, 2011LETTER OF SUSPENSION E-MAILED
Thursday, May 12, 2011SUSPENSION LETTER WRITTEN
Thursday, May 12, 2011ASSIGNED TO EXAMINER
Wednesday, February 16, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 15, 2011NEW APPLICATION ENTERED IN TRAM